Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 17:00 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
An Initial Study of Lithium in Patients With Medullary Thyroid Cancer
NCT00582712 · University of Wisconsin, Madison · PHASE2 · terminated · last registry update 2019-12-09 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Budget/Funding” | – | Registry record, University of Wisconsin, Madison |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against IMPA1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2020-11-10Phase 3 first posted: Assistance Publique - Hôpitaux de Paris, Lithium Carbonate + Placebo (NCT04623398)
- 2020-10-30Results posted on the registry: Forbes Norris MDA/ALS Research Center, lithium carbonate (NCT00790582)
- 2020-10-19Results posted on the registry: University of Pennsylvania, Lithium / Fluoxetine + Lithium / Placebo (NCT00961961)
- 2020-10-14Results posted on the registry: Federal University of Rio Grande do Sul, Lithium Carbonate + Sertraline (NCT02918097)
- 2020-10-14Results posted on the registry: Federal University of Rio Grande do Sul, sertraline + Nortriptyline (NCT02901249)
- 2020-09-02Results posted on the registry: Federal University of Rio Grande do Sul, Lithium + Valproic Acid (NCT02870283)
- 2020-08-14Results posted on the registry: The University of Texas Health Science Center at San Antonio, Lithium + Divalproex (NCT01588457)
- 2020-07-10Results posted on the registry: Keming Gao, Lithium (NCT02909504)
- 2020-07-10Also stopped (terminated): Keming Gao, Lithium (NCT02909504)
- 2020-03-25Also stopped (terminated): Institut Cancerologie de l'Ouest, Blood sample for phenotypic and pharmacogenetic analysis. + Blood sample for phenotypic and pharmacogenetic analysis. (NCT01547923)
- 2020-01-10Also stopped (terminated): Aziende Chimiche Riunite Angelini Francesco S.p.A, Lithium sulphate prolonged-release 660 mg + Lithium carbonate immediate-release 150 mg and 300 mg (NCT03210480)
- 2019-09-16Results posted on the registry: Organon and Co, Asenapine + Placebo (NCT00145470)
- 2019-09-10Results posted on the registry: VA Office of Research and Development, Lithium Carbonate (NCT01259388)
- 2019-04-01Also stopped (withdrawn): Smith & Nephew, Inc., a drug against IMPA1 (NCT02883010)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision